ASPCU
Price
$10.07
Change
+$0.01 (+0.10%)
Updated
Dec 18 closing price
RENE
Price
$11.64
Change
-$0.00 (-0.00%)
Updated
Dec 18 closing price
Ad is loading...

ASPCU vs RENE

Header iconASPCU vs RENE Comparison
Open Charts ASPCU vs RENEBanner chart's image
A SPAC III Acquisition
Price$10.07
Change+$0.01 (+0.10%)
Volume$601
CapitalizationN/A
Cartesian Growth
Price$11.64
Change-$0.00 (-0.00%)
Volume$2.15K
CapitalizationN/A
ASPCU vs RENE Comparison Chart
Loading...
RENE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASPCU vs. RENE commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASPCU is a Buy and RENE is a Buy.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (ASPCU: $10.07 vs. RENE: $11.65)
Brand notoriety: ASPCU and RENE are both not notable
Both companies represent the Financial Conglomerates industry
Current volume relative to the 65-day Moving Average: ASPCU: 1% vs. RENE: 2%
Market capitalization -- ASPCU: $0 vs. RENE: $239.99M
ASPCU [@Financial Conglomerates] is valued at $0. RENE’s [@Financial Conglomerates] market capitalization is $239.99M. The market cap for tickers in the [@Financial Conglomerates] industry ranges from $590.24B to $0. The average market capitalization across the [@Financial Conglomerates] industry is $2.71B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASPCU’s FA Score shows that 0 FA rating(s) are green whileRENE’s FA Score has 0 green FA rating(s).

  • ASPCU’s FA Score: 0 green, 5 red.
  • RENE’s FA Score: 0 green, 5 red.
According to our system of comparison, ASPCU is a better buy in the long-term than RENE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RENE’s TA Score shows that 1 TA indicator(s) are bullish.

  • RENE’s TA Score: 1 bullish, 0 bearish.

Price Growth

ASPCU (@Financial Conglomerates) experienced а +0.29% price change this week, while RENE (@Financial Conglomerates) price change was +0.04% for the same time period.

The average weekly price growth across all stocks in the @Financial Conglomerates industry was -0.78%. For the same industry, the average monthly price growth was +5.02%, and the average quarterly price growth was +29.23%.

Reported Earning Dates

RENE is expected to report earnings on May 05, 2023.

Industries' Descriptions

@Financial Conglomerates (-0.78% weekly)

Financial conglomerates usually encompass a wide range of financial services including (not necessarily limited to) investment banking, insurance, capital raising/underwriting, trading of financial securities, investment advisory services, wealth management of high net-worth individuals, and retail banking. Think Citigroup, American Express Company, ING Group.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RENE has higher annual earnings (EBITDA): -2.03M vs. ASPCU (-3.36M). ASPCU has more cash in the bank: 69.4K vs. RENE (50.9K). ASPCU has less debt than RENE: ASPCU (150K) vs RENE (3.98M). ASPCU (0) and RENE (0) have equivalent revenues.
ASPCURENEASPCU / RENE
CapitalizationN/A240M-
EBITDA-3.36M-2.03M165%
Gain YTDN/A6.444-
P/E RatioN/A27.07-
Revenue00-
Total Cash69.4K50.9K136%
Total Debt150K3.98M4%
TECHNICAL ANALYSIS
Technical Analysis
RENE
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
27%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
35%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
34%
Advances
ODDS (%)
N/A
Declines
ODDS (%)
N/A
BollingerBands
ODDS (%)
N/A
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Ad is loading...
RENE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GIIGX23.860.04
+0.17%
Gabelli International Growth I
JSCBX18.87N/A
N/A
JHancock Small Cap Value I
HSWCX17.80-0.07
-0.39%
Hartford Schroders International Stk C
JDSNX23.57-0.37
-1.55%
Janus Henderson Small Cap Value N
CRRVX9.69-0.41
-4.06%
Columbia Real Estate Equity Inst2

ASPCU and

Correlation & Price change

A.I.dvisor tells us that ASPCU and INAQU have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ASPCU and INAQU's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASPCU
1D Price
Change %
ASPCU100%
N/A
INAQU - ASPCU
27%
Poorly correlated
N/A
RENE - ASPCU
26%
Poorly correlated
N/A
BEAG - ASPCU
10%
Poorly correlated
N/A
RILY - ASPCU
7%
Poorly correlated
+0.81%
ISRL - ASPCU
6%
Poorly correlated
-0.26%
More

RENE and

Correlation & Price change

A.I.dvisor tells us that RENE and LATG have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RENE and LATG's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RENE
1D Price
Change %
RENE100%
-0.04%
LATG - RENE
33%
Poorly correlated
N/A
CMCAF - RENE
32%
Poorly correlated
N/A
HYAC - RENE
31%
Poorly correlated
N/A
BRAC - RENE
28%
Poorly correlated
N/A
WTMA - RENE
26%
Poorly correlated
N/A
More